Business Context and Reporting Period
This Form 8-K Current Report was filed by Lightwave Logic, Inc. on January 11, 2022, with the earliest event reported on that date. The filing addresses corporate governance changes, specifically the resignation of a director and the election of a new director to the Board.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on personnel changes within the Board of Directors.
Material Changes
- Resignation: Dr. Joseph A. Miller tendered his resignation as a director, effective January 17, 2022. The filing states this resignation is not the result of any disagreement with the Company, management, or the Board.
- Appointment: The Board elected Dr. Craig Ciesla as a new Class II director, effective January 17, 2022. His term continues until the 2022 Annual Meeting of Shareholders or until a successor is appointed.
- Committee Assignments: Dr. Ciesla was named to serve on the Audit Committee and the Nominating and Corporate Governance Committee.
Outlook, Risks, and Management Commentary
Management Commentary: The Company highlighted Dr. Ciesla's extensive background in photonics and data-center technology. He is currently the Vice President, Head of the Advanced Platforms and Devices Group at Illumina. His prior experience includes roles at Kaiam, Tactus Technology, Intel, JDSU (now Lumentum), Bookham (now Oclaro), Ignis Optics, and Toshiba Research Europe.
Compensation: Dr. Ciesla will receive compensation commensurate with other non-employee directors. Specific compensation details were not included in this filing but will be disclosed in an amendment within four business days of determination.
Risks and Contingencies: No specific financial risks or contingencies were disclosed in this report.
Key Facts for Investor Verification
- Verify the effective date of Dr. Miller's resignation (January 17, 2022) and Dr. Ciesla's appointment.
- Monitor for the upcoming amendment to this Form 8-K detailing Dr. Ciesla's specific compensation package.
- Review Dr. Ciesla's background to assess the strategic fit for the Audit and Nominating committees.
- Confirm that the resignation of Dr. Miller was not related to any undisclosed disagreements or governance issues.